Remove connect collection open-science
article thumbnail

Driving clinical trial innovation forward with precision medicine

pharmaphorum

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Drop-out rates and data collection. Digital technology and ‘frictionless’ clinical trials.

article thumbnail

Insights from Industry Experts: Examining the Patient Experience in Clinical Trial Design

Worldwide Clinical Trials

Perez , CCRP are joined by Sandra Ojeda, PhD, the Science Director of the Glut1 Deficiency Foundation to discuss specific case studies from their experiences incorporating the patient experience into clinical trial design. Mills , MS, MPH, and Director & Global Head of Health Equity Strategy, Daniel A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hollywood and the Metaverse’s effect on pharma’s content

pharmaphorum

Currently, pharma is primarily using digital means to connect with its customers, and Kapoor says it’s discovering from Hollywood how to create engaging content that is more customer focused. Let’s say someone receives an email but will not open it because of the subject line. People used to say email is effective.

Branding 115
article thumbnail

Key findings from life sciences digital pathology adoption survey 

Drug Discovery World

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. The post Key findings from life sciences digital pathology adoption survey appeared first on Drug Discovery World (DDW).

article thumbnail

Xtalks Talent Acquisition & Branding Bundle: Position Your Organization to Attract Elite Talent

XTalks

Enter the Xtalks’ Talent Acquisition & Branding Bundle (TABB) — a multifaceted solution designed to elevate your organization’s visibility, profile and allure within our globally-renowned community in the life sciences industry. What Is Xtalks’ Talent Acquisition & Branding Bundle (TABB)?

article thumbnail

Medical affairs in a digital-first world: Benefits and challenges

Pharmaceutical Technology

Acting as a go-between for pharma and physicians, medical science liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). The insights gathered here may tell a different story compared to those collected in a tightly controlled clinical trial.

Medicine 130
article thumbnail

The post-Covid New Normal: a golden opportunity for the NHS?

pharmaphorum

I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. Faster access for patients for interventions. Data on all aspects, including stratification of patient types. Reducing complexity across the NHS.